Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-03-30

Clinical Trial Update: The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a GnRH Agonist for Endometriosis: A Randomized Trial [Phase 2]

View source ↗

Summary

Results from a Phase 2 randomized trial evaluating hormonal add-back therapy in adolescents treated with a GnRH agonist for endometriosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boston Children's Hospital | Conditions: Endometriosis | Phase 2 | Status: COMPLETED | Results posted: 2015-03-30